Web Analytics

Investor Profile

3E Bioventures Capital

3E Bioventures Capital China - Beijing, Haidian District
INVESTOR

1 Disclosed Funding Rounds $35,500,000
4 Participating Investments




3E Bioventures Capital is a healthcare focused venture investment fund. The core 3E investment team members are all trained in biomedical fields, with healthcare industry experience and years

Invested In

Company Date Round Raised
  Larkspur Biosciences May, 24 ,2023 Unknown $35,500,000
  Smartlens July, 12 ,2023 Series A $6,100,000
  Myrobalan Therapeutics January, 11 ,2024 Series A $24,000,000
  Rapafusyn Pharmaceuticals June, 25 ,2024 Series A $28,000,000